|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
EP0377676B1
(en)
|
1987-09-17 |
1995-05-24 |
Massachusetts Institute Of Technology |
Human erythroid-specific transcriptional enhancer
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
WO1992001070A1
(en)
|
1990-07-09 |
1992-01-23 |
The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce |
High efficiency packaging of mutant adeno-associated virus using amber suppressions
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
JP3534749B2
(ja)
|
1991-08-20 |
2004-06-07 |
アメリカ合衆国 |
アデノウイルスが介在する胃腸管への遺伝子の輸送
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6004797A
(en)
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
|
US6027721A
(en)
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
ATE351916T1
(de)
|
1999-10-12 |
2007-02-15 |
Pasteur Institut |
Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten
|
|
CA2406743A1
(en)
|
2000-04-28 |
2001-11-08 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
US20070037165A1
(en)
*
|
2000-09-08 |
2007-02-15 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
|
GB0024550D0
(https=)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
EP1412493B1
(en)
|
2001-08-02 |
2011-10-05 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
|
EP1438075A4
(en)
|
2001-10-02 |
2006-04-19 |
Inst Clayton De La Rech |
METHOD AND COMPOSITIONS ASSOCIATED WITH LENTIVIRAL VECTORS WITH LIMITED EXPRESSION AND ITS APPLICATIONS
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
NZ536899A
(en)
|
2002-05-02 |
2008-04-30 |
Univ Rochester |
Vectors having both isoforms of beta-hexosaminidase
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
EP1529105B1
(en)
|
2002-08-12 |
2012-10-03 |
Société de commercialisation des produits de la recherche appliquée SOCPRA Sciences Santé et Humaines s.e.c. |
Methods to reprogram splice site selection in pre-messenger rnas
|
|
WO2004094642A2
(en)
|
2003-04-24 |
2004-11-04 |
Fondazione Centro San Raffaele Del Monte Tabor |
Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
|
|
US7960100B1
(en)
*
|
2004-04-30 |
2011-06-14 |
Celera Corporation |
Colon cancer targets and uses thereof
|
|
JP2007054069A
(ja)
|
2005-08-24 |
2007-03-08 |
Medizinische Hochschule Hannover |
自己不活性化レトロウイルスベクター
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
EP2152889B1
(en)
|
2007-05-29 |
2017-03-15 |
Nature Technology Corporation |
Vectors and methods for genetic immunization
|
|
WO2009012176A2
(en)
|
2007-07-14 |
2009-01-22 |
The University Of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
WO2009126894A2
(en)
*
|
2008-04-11 |
2009-10-15 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for the diagnosis and treatment of angiogenic disorders
|
|
AU2010241864B2
(en)
|
2009-04-30 |
2014-02-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
DE102009021592A1
(de)
|
2009-05-15 |
2010-11-18 |
Medizinische Hochschule Hannover |
ASLV-Vektorsystem
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
AU2013221212B2
(en)
|
2012-02-17 |
2018-08-09 |
The Children's Hospital Of Philadelphia |
AAV vector compositions and methods for gene transfer to cells, organs and tissues
|
|
KR102530118B1
(ko)
|
2012-07-25 |
2023-05-08 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
GB201318347D0
(en)
|
2013-10-16 |
2013-11-27 |
Ucl Business Plc |
Retroviral vectors
|
|
CN120174012A
(zh)
|
2013-10-24 |
2025-06-20 |
优尼科Ip有限公司 |
用于基因治疗神经疾病的aav-5假型载体
|
|
CN107405411A
(zh)
|
2014-05-01 |
2017-11-28 |
华盛顿大学 |
使用腺病毒载体的体内基因改造
|
|
IL248102B
(en)
|
2014-05-02 |
2022-07-01 |
Genzyme Corp |
aav vectors for gene therapy of the central nervous system and retina
|
|
US11030531B2
(en)
|
2014-06-06 |
2021-06-08 |
Trustees Of Boston University |
DNA recombinase circuits for logical control of gene expression
|
|
US10781459B2
(en)
|
2014-06-20 |
2020-09-22 |
University Of Florida Research Foundation, Incorporated |
Methods of packaging multiple adeno-associated virus vectors
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
US10350245B2
(en)
|
2015-01-21 |
2019-07-16 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
CN107635575A
(zh)
|
2015-03-10 |
2018-01-26 |
纽约市哥伦比亚大学理事会 |
重组glut1腺相关病毒载体构建体以及用于恢复glut1表达的相关方法
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
WO2017083750A1
(en)
*
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
KR102423442B1
(ko)
|
2015-12-11 |
2022-07-20 |
캘리포니아 인스티튜트 오브 테크놀로지 |
아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
|
|
DK3405215T3
(da)
|
2016-01-19 |
2022-09-19 |
Univ California |
Fremgangsmåder til behandling af danon-sygdom og andre autofagilidelser
|
|
WO2017136536A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
CA3021572A1
(en)
|
2016-04-20 |
2017-10-26 |
Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas |
Compositions and methods for enhanced gene expression of pklr
|
|
CN110536966A
(zh)
|
2016-09-08 |
2019-12-03 |
能源环境和技术研究中心O.A.,M.P. |
用于范可尼贫血患者的基因疗法
|
|
JP7059285B2
(ja)
|
2016-09-30 |
2022-04-25 |
エステベ プアルマセウティカルス， エッセ．ア． |
ムコ多糖症の治療のためのアデノ随伴ウイルスベクター
|
|
US20180326022A1
(en)
*
|
2017-04-21 |
2018-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for improving heart function and treating heart failure
|
|
US20200199534A1
(en)
|
2017-04-27 |
2020-06-25 |
Fred Hutchinson Cancer Research Center |
Therapeutic formulations containing cd34+ stem cells derived from negative selection
|
|
EP3622062A4
(en)
|
2017-05-10 |
2020-10-14 |
The Regents of the University of California |
DIRECTED EDITING OF CELLULAR RNA BY NUCLEAR ADMINISTRATION OF CRISPR / CAS9
|
|
US12186369B2
(en)
*
|
2017-09-20 |
2025-01-07 |
The Regents Of The University Of California |
Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy
|
|
EP3694996A1
(en)
*
|
2017-10-12 |
2020-08-19 |
Universität Heidelberg |
Kcnk3-based gene therapy of cardiac arrhythmia
|
|
EP3697452A4
(en)
|
2017-10-16 |
2021-11-24 |
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. |
LENTIVIRAL VECTORS FOR ADMINISTRATION OF PKLR TO TREAT PYRUVATE KINASE DEFECTS
|
|
BR112020020841A2
(pt)
|
2018-04-11 |
2021-01-19 |
Fundacion Para La Investigacion Biomedica Del Hospital Infantil Universitario Nino Jesus |
Composições e métodos para transplante de célulastronco
|
|
CA3096293A1
(en)
*
|
2018-04-27 |
2019-10-31 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy for cns degeneration
|
|
AU2019258830B2
(en)
|
2018-04-27 |
2025-12-18 |
Universität Heidelberg |
Modified AAV capsid polypeptides for treatment of muscular diseases
|
|
WO2020014523A1
(en)
|
2018-07-12 |
2020-01-16 |
Rocket Pharmaceuticals, Ltd. |
Gene therapy vectors for treatment of danon disease
|
|
KR20210046004A
(ko)
|
2018-07-30 |
2021-04-27 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
조혈 세포의 유전자 변형 방법
|
|
EP3833745A1
(en)
|
2018-08-10 |
2021-06-16 |
REGENXBIO Inc. |
Scalable method for recombinant aav production
|
|
JP2021533831A
(ja)
|
2018-08-16 |
2021-12-09 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
ウイルスベクターのための生成方法
|
|
US20220088052A1
(en)
|
2019-01-22 |
2022-03-24 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Tfap2 inhibition for treating cardiac disease involving fibro-fatty replacement
|
|
AU2020221842A1
(en)
*
|
2019-02-12 |
2021-08-12 |
Spacecraft Seven, Llc |
Gene therapy vectors for treatment of Danon Disease
|
|
CN113994008A
(zh)
|
2019-05-23 |
2022-01-28 |
太空飞船七有限责任公司 |
用于婴儿恶性骨硬化病的基因治疗载体
|
|
KR20220066914A
(ko)
*
|
2019-09-20 |
2022-05-24 |
유씨엘 비즈니스 리미티드 |
부정맥 유발성 우심실 심근병증의 유전자 요법 조성물 및 치료
|
|
WO2021163357A2
(en)
|
2020-02-13 |
2021-08-19 |
Tenaya Therapeutics, Inc. |
Gene therapy vectors for treating heart disease
|
|
WO2021187380A1
(ja)
|
2020-03-16 |
2021-09-23 |
国立大学法人大阪大学 |
不整脈源性心筋症患者由来の多能性幹細胞およびその利用ならびに不整脈源性心筋症治療用医薬
|
|
IL297391A
(en)
|
2020-04-20 |
2022-12-01 |
Tenaya Therapeutics Inc |
An adeno-associated virus with an engineered capsid
|
|
JP2023535121A
(ja)
|
2020-05-20 |
2023-08-16 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
操作されたパーキン及びその使用
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
AU2021321412A1
(en)
|
2020-08-05 |
2023-04-06 |
Spacecraft Seven, Llc |
Adeno-associated viral vector for GLUT1 expression and uses thereof
|
|
BR112023001336A2
(pt)
|
2020-08-05 |
2023-02-14 |
Spacecraft Seven Llc |
Terapia gênica de csrp3 (proteína 3 rica em cisteína e glicina)
|
|
JP2023538519A
(ja)
|
2020-08-07 |
2023-09-08 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
Ａａｖベクターを使用したプラコフィリン－２（ｐｋｐ２）遺伝子治療
|
|
IL301675A
(en)
|
2020-10-09 |
2023-05-01 |
Tenaya Therapeutics Inc |
Methods and preparations for placophilin-2 gene therapy
|
|
CA3201247A1
(en)
|
2020-12-07 |
2022-06-16 |
Gaurav Shah |
Treatment of danon disease
|
|
KR20230159471A
(ko)
|
2021-03-19 |
2023-11-21 |
유씨엘 비즈니스 리미티드 |
우심실 부정맥성 심근병증의 유전자 치료 조성물 및 치료
|
|
MX2023011875A
(es)
|
2021-04-12 |
2024-01-05 |
Univ California |
Tratamiento genico para miocardiopatía arritmogénica del ventriculo derecho.
|
|
AU2022307365A1
(en)
|
2021-07-08 |
2024-02-01 |
Tenaya Therapeutics, Inc. |
Optimized expression cassettes for gene therapy
|